Tacrolimus asociado a encefalopatía posterior reversible atípica y hemorragia cerebral en receptor de trasplante renal

Cadavid-Aljure, Dahyana; Meza, Juan C; Caicedo-Paredes, Andrea; Granados-Sánchez, Ana M; Posada-Chávez, Juan G; Mesa-Ramírez, Liliana; Schweineberg-López, Johanna.
Nefrología (Madr.) ; 32(6): 861-863, nov.-dic. 2012. ilus
Artículo en Español | IBECS (España) | ID: ibc-110515

Documentos relacionados

  1. Perfusion-Dependent Focal Neurologic Deficits in a Critically Ill Heart Transplant Recipient: A Case of Tacrolimus-Associated Reversible Cerebral Vasospasm Syndrome?
  2. Cabozantinib-related posterior reversible encephalopathy syndrome.
  3. Acute Neurological Symptoms After a Liver Transplant.
  4. Tacrolimus Induced Thrombotic Microangiopathy (TMA) Presenting as Acute Macular Neuroretinopathy.
  5. Tacrolimus-Induced Neurotoxicity After Transplant: A Literature Review.
  6. Posterior reversible encephalopathy syndrome after lung transplantation: Risk factors and management.
  7. Amphetamine and Clonidine Toxicity Resulting in Posterior Reversible Encephalopathy Syndrome.
  8. Rare anti-VEGFR therapy-induced toxicity and long-term response to immunotherapy in a rare non-clear cell renal cell carcinoma patient.
  9. Posterior Reversible Encephalopathy Syndrome After Orthotopic Heart Transplantation: A Case Report.
  10. The first two cases of posterior reversible encephalopathy syndrome (PRES) secondary to conventional transcatheter arterial chemoembolization of hepatocellular carcinoma.